A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
D000293:Adolescent; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001288:Attention / Q000187:drug effects; D001925:Brain Damage, Chronic / Q000188:drug therapy; D002090:Butyrophenones / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D002675:Child, Preschool; D005461:Fluorine / Q000627:therapeutic use*; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy; D012561:Schizophrenia, Childhood / Q000188:drug therapy; D014272:Trifluperidol / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D010880:Piperidines; D005461:Fluorine; D001219:Aspartate Aminotransferases; D014272:Trifluperidol